Tshawb Nrhiav | Blue Cross MN

Nthuav pom cov txiaj ntsig tshwm sim 2401 - 2410 ntawm 3685

Tus kws kho mob

P67-20 Radiation Oncology Clinical Guideline Updates for Fully Insured Commercial and Medicare Advantage Subscribers – eviCore Healthcare Specialty Utilization Management (UM) Program

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 01, 2020

Tus kws kho mob

P74-20 New Medical, Medical Drug and Behavioral Health Policy Management Updates—Effective November 30, 2020

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020

Tus kws kho mob

P75-20 Removal of Six Commercial Prior Authorization Requirements—Effective November 16, 2020

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Kaum Hlis Ntuj Tim 01, 2020

Tus kws kho mob

QP91-20 MHCP Pharmacy Benefit Exclusion for Tecartus™, Monjuvi™ and Blenrep

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 23, 2020

Tus kws kho mob

QP87-20 Minnesota Health Care Programs (MHCP) FQHC/RHC Provider Service

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020

Tus kws kho mob

QP84-20 Multiple Medicaid Coverages Listed on the Same Claim

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020

Tus kws kho mob

QP90-20 Medical Injectable Step Therapy Override Request for Minnesota Health Care Programs (MHCP)

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020

Tus kws kho mob

QP89-20 MHCP Pharmacy Benefit Exclusion for Viltepso®

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020

Tus kws kho mob

QP86-20 Medical Drug Update for New to Market Tanezumab

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020

Tus kws kho mob

QP85-20 Commercial Pharmacy Benefit Exclusion for Tecartus™

Nyeem Ntxiv

Hnub Tim pib siv tau lub khoos kas: Lub Cuaj Hlis Ntuj Tim 09, 2020